LAMDA DEVELOPMENT ΑΝΩΝΥΜΗ ΕΤΑΙΡΕΙΑ ΣΥΜΜΕΤΟΧΩΝ ΚΑΙ ΑΞΙΟΠΟΙΗΣΗΣ ΑΚΙΝΗΤΩΝ financials
LAMDA DEVELOPMENT ΑΝΩΝΥΜΗ ΕΤΑΙΡΕΙΑ ΣΥΜΜΕΤΟΧΩΝ ΚΑΙ ΑΞΙΟΠΟΙΗΣΗΣ ΑΚΙΝΗΤΩΝ
Country: GR Reporting currency: EUR Latest annual report: 2024-12-31
LEI:
213800C7PQZVF38FYL54 Financial statements
(EUR, as reported — unscaled; 133 line items across 2 annual periods)
| Line item | 2024 | 2023 |
|---|---|---|
| Income statement | ||
| Revenue | €665.0M | €450.6M |
| Employee benefits expense | €50.9M | €50.5M |
| Depreciation & amortisation | €12.1M | €11.3M |
| Operating profit (EBIT) | €185.1M | €187.8M |
| Finance costs | €127.1M | €140.4M |
| Profit before tax | €77.0M | €57.3M |
| Income tax expense | €29.5M | €30.2M |
| Profit for the year | €47.5M | €27.1M |
| — attributable to owners | €46.3M | €27.0M |
| — attributable to NCI | €1.2M | €119.0K |
| Total comprehensive income | €44.3M | €23.5M |
| Per share | ||
| Basic EPS | €0.27 | €0.16 |
| Diluted EPS | €0.26 | €0.16 |
| Cash flow statement | ||
| Net cash from operating activities | €357.9M | €121.4M |
| Income taxes paid | €17.8M | €42.8M |
| Net cash from investing activities | -€92.8M | -€65.5M |
| Purchase of intangibles | €1.7M | €605.0K |
| Net cash from financing activities | -€87.0M | -€107.3M |
| Proceeds from borrowings | €675.7M | €262.0M |
| Repayments of borrowings | €650.9M | €280.5M |
| Lease liability payments | €4.3M | €4.2M |
| Balance sheet | ||
| Total assets | €4.43B | €4.15B |
| Non-current assets | €3.16B | €3.27B |
| Property, plant & equipment | €89.4M | €82.9M |
| Right-of-use assets | €136.8M | €136.6M |
| Intangible assets & goodwill | €20.0M | €19.8M |
| Inventories | €406.1M | €251.3M |
| Trade & other receivables | €218.1M | €140.9M |
| Cash & equivalents | €642.2M | €464.1M |
| Total equity | €1.25B | €1.19B |
| — attributable to owners | €1.23B | €1.18B |
| Non-controlling interests | €14.2M | €13.4M |
| Non-current liabilities | €2.47B | €2.05B |
| Long-term borrowings | €1.15B | €757.8M |
| Lease liabilities (non-current) | €196.4M | €190.7M |
| Lease liabilities (current) | €4.3M | €3.8M |
| Trade & other payables | €496.3M | €339.0M |
| Deferred tax liabilities | €218.7M | €215.9M |
| Derived metrics | ||
| Operating margin | 27.8% | 41.7% |
| Net margin | 7.1% | 6.0% |
| Return on equity | 3.8% | 2.3% |
| Cash conversion ratio | 7.54× | 4.47× |
| Other reported items | ||
| Adjusted Weighted Average Shares | 174.6M | 173.9M |
| Adjustments For Decrease Increase In Inventories | -€112.8M | -€4.0M |
| Adjustments For Decrease Increase In Trade and Other Receivables | €84.3M | €28.4M |
| Adjustments For Depreciation and Amortisation Expense | €12.1M | €11.3M |
| Adjustments For Dividend Income | €135.0K | €406.0K |
| Adjustments For Finance Costs | €127.1M | €140.4M |
| Adjustments For Finance Income | €19.2M | €10.4M |
| Adjustments For Gain Loss On Disposal of Investments In Subsidiaries Joint Ventures and Associates | €612.0K | €6.0M |
| Adjustments For Gains Losses On Fair Value Adjustment Investment Property | €22.9M | €97.3M |
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €0 | €0 |
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss Inventories | €1.9M | €29.1M |
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss Loans and Advances | €0 | €0 |
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss Trade and Other Receivables | -€707.0K | -€527.0K |
| Adjustments For Income Tax Expense | €29.5M | €30.2M |
| Adjustments For Increase Decrease In Trade and Other Payables | -€150.9M | -€72.9M |
| Adjustments For Sharebased Payments | €5.4M | €5.0M |
| Adjustments For Undistributed Profits of Investments Accounted For Using Equity Method | -€177.0K | -€465.0K |
| Cash Advances and Loans Made To Related Parties | €0 | €0 |
| Cash Flows From Losing Control of Subsidiaries Or Other Businesses Classified As Investing Activities | €3.9M | €10.4M |
| Cash Flows From Used In Decrease Increase In Restricted Cash and Cash Equivalents | €0 | €167.0M |
| Cash Flows From Used In Operations Before Changes In Working Capital | €175.9M | €136.5M |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | €0 | €179.8M |
| Cash Receipts From Repayment of Advances and Loans Made To Related Parties | €0 | €0 |
| Comprehensive Income Attributable To Noncontrolling Interests | €1.2M | €119.0K |
| Comprehensive Income Attributable To Owners of Parent | €43.0M | €23.4M |
| Cost of Inventories Recognised As Expense During Period | €322.4M | €163.2M |
| Current Assets Other Than Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners | €1.28B | €870.2M |
| Current Borrowings and Current Portion of Noncurrent Borrowings | €24.5M | €386.1M |
| Current Derivative Financial Assets | €194.0K | €0 |
| Current Derivative Financial Liabilities | €625.0K | €0 |
| Current Liabilities Other Than Liabilities Included In Disposal Groups Classified As Held For Sale | €718.5M | €904.0M |
| Current Restricted Cash and Cash Equivalents | €5.5M | €12.1M |
| Current Tax Assets | €5.3M | €1.8M |
| Current Tax Liabilities | €20.5M | €5.6M |
| Deferred Tax Assets | €4.9M | €753.0K |
| Direct Operating Expense From Investment Property | €19.1M | €18.8M |
| Dividends Paid To Noncontrolling Interests Classified As Financing Activities | €455.0K | €342.0K |
| Dividends Received Classified As Operating Activities | -€406.0K | -€135.0K |
| Dividends Recognised As Distributions To Noncontrolling Interests | €809.0K | €562.0K |
| Equity and Liabilities | €4.43B | €4.15B |
| Finance Income | €19.2M | €10.4M |
| Gains Losses On Cash Flow Hedges Net of Tax | -€2.9M | -€3.6M |
| Gains Losses On Exchange Differences On Translation Net of Tax | €110.0K | -€36.0K |
| Gains Losses On Fair Value Adjustment Investment Property | €22.9M | €97.3M |
| Gains On Disposals of Investment Properties | €4.1M | €0 |
| Gains On Disposals of Investments | €612.0K | €6.0M |
| Impairment Loss Recognised In Profit Or Loss | €0 | €0 |
| Impairment Loss Recognised In Profit Or Loss Loans and Advances | €0 | €0 |
| Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €0 | €7.6M |
| Increase Decrease In Cash and Cash Equivalents | €178.1M | -€51.4M |
| Increase Decrease In Net Defined Benefit Liability Asset | -€6.0K | -€29.0K |
| Increase Decrease In Working Capital | €199.7M | €27.8M |
| Increase Decrease Through Change In Equity of Subsidiaries | €298.0K | — |
| Increase Decrease Through Changes In Ownership Interests In Subsidiaries That Do Not Result In Loss of Control | €0 | — |
| Increase Decrease Through Transactions With Owners | €10.9M | -€312.0K |
| Increase Decrease Through Transfer To Statutory Reserve | €0 | €0 |
| Increase Decrease Through Treasury Share Transactions | €0 | €0 |
| Interest Paid Classified As Financing Activities | €61.8M | €60.8M |
| Interest Received Classified As Investing Activities | €15.1M | €7.2M |
| Investment Accounted For Using Equity Method | €45.0M | €36.5M |
| Investment Property | €2.27B | €2.15B |
| Investments In Subsidiaries | €0 | €0 |
| Liabilities | €3.19B | €2.96B |
| Liabilities Included In Disposal Groups Classified As Held For Sale | €0 | €6.5M |
| Noncurrent Assets Or Disposal Groups Classified As Held For Sale | €0 | €15.3M |
| Noncurrent Derivative Financial Assets | €385.0K | €6.5M |
| Noncurrent Derivative Financial Liabilities | €3.3M | €0 |
| Noncurrent Inventories | €516.3M | €810.4M |
| Noncurrent Receivables | €42.9M | €6.6M |
| Noncurrent Recognised Liabilities Defined Benefit Plan | €1.5M | €992.0K |
| Noncurrent Restricted Cash and Cash Equivalents | €31.2M | €11.5M |
| Other Comprehensive Income | -€3.2M | -€3.6M |
| Other Comprehensive Income Net of Tax Gains Losses On Remeasurements of Defined Benefit Plans | -€376.0K | -€18.0K |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax | -€2.8M | -€3.6M |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net of Tax | -€376.0K | -€18.0K |
| Other Inflows Outflows of Cash Classified As Investing Activities | -€15.7M | -€14.2M |
| Other Noncurrent Financial Assets | €3.8M | €3.5M |
| Other Noncurrent Liabilities | €16.3M | €17.9M |
| Other Operating Income Expense | -€101.4M | -€86.0M |
| Other Reserves | €32.5M | €30.4M |
| Payments For Debt Issue Costs | €3.6M | €398.0K |
| Payments To Acquire Or Redeem Entitys Shares | €23.9M | €8.8M |
| Proceeds From Sale Or Issue of Treasury Shares | €25.0M | €0 |
| Purchase of Treasury Shares | €23.8M | €8.9M |
| Retained Earnings | €190.7M | €143.1M |
| Revenue From Dividends | €135.0K | €406.0K |
| Sale Or Issue of Treasury Shares | €25.1M | — |
| Share of Profit Loss of Associates and Joint Ventures Accounted For Using Equity Method | -€177.0K | -€465.0K |
| Treasury Shares | €15.9M | €20.6M |
| Weighted Average Shares | 174.2M | 173.9M |
| Writedowns Reversals of Inventories | €1.9M | €29.1M |
Methodology
Every line item above is a fact tagged in LAMDA DEVELOPMENT ΑΝΩΝΥΜΗ ΕΤΑΙΡΕΙΑ ΣΥΜΜΕΤΟΧΩΝ ΚΑΙ ΑΞΙΟΠΟΙΗΣΗΣ ΑΚΙΝΗΤΩΝ's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.